The Oncosearch | Oncotarget

A comparison of R-EPOCH and R-CHOP as a first-line regimen in de novo DLBCL patients with high Ki-67 expression in a single institution Research Paper

Jia-Jia Huang, Yi Xia, Yu Wang, Pan-Pan Liu, Xi-Wen Bi, Peng Sun, Tong-Yu Lin, Wen-Qi Jiang, Zhi-Ming Li

Published May 10, 2016 · Vol. 7, No. 27 · pp. 41242-41250

Thalidomide enhanced the efficacy of CHOP chemotherapy in the treatment of diffuse large B cell lymphoma: A phase II study Research Paper

Dongmei Ji, Qiu Li, Junning Cao, Ye Guo, Fangfang Lv, Xiaojian Liu, Biyun Wang, Leiping Wang, Zhiguo Luo, Jianhua Chang, Xianghua Wu, Xiaonan Hong

Published Apr 25, 2016 · Vol. 7, No. 22 · pp. 33331-33339

The impact of adjuvant chemotherapy in older breast cancer patients on clinical and biological aging parameters Research Paper

Barbara Brouwers, Sigrid Hatse, Lissandra Dal Lago, Patrick Neven, Peter Vuylsteke, Bruna Dalmasso, Guy Debrock, Heidi Van Den Bulck, Ann Smeets, Oliver Bechter, Jithendra Kini Bailur, Cindy Kenis, Annouschka Laenen, Patrick SchÃ¶ffski, Graham Pawelec, Fabrice Journe, Ghanem-Elias Ghanem, Hans Wildiers

Published Apr 18, 2016 · Vol. 7, No. 21 · pp. 29977-29988

Cardiotoxicity as indicated by LVEF and troponin T sensitivity following two anthracycline-based regimens in lymphoma: Results from a randomized prospective clinical trial Research Paper

Kai Xue, Juan J. Gu, Qunling Zhang, Xiaojian Liu, Jiachen Wang, Xiao-qiu Li, Jianfeng Luo, Francisco J. Hernandez-Ilizaliturri, Stanley F. Fernandez, Myron S. Czuczman, Junning Cao, Xiaonan Hong, Ye Guo

Published Apr 11, 2016 · Vol. 7, No. 22 · pp. 32519-32531

A four gene signature of chromosome instability (CIN4) predicts for benefit from taxanes in the NCIC-CTG MA21 clinical trial Research Paper

Melanie Spears, Nicola Lyttle, Alister D'Costa, Bingshu E. Chen, Cindy Q. Yao, Paul C. Boutros, Margot Burnell, Mark N. Levine, Patti O'Brien, Lois Shepherd, John M.S. Bartlett

Published Apr 1, 2016 · Vol. 7, No. 31 · pp. 49099-49106

Tumor necrosis factor receptor 2-signaling in CD133-expressing cells in renal clear cell carcinoma Research Paper

Rafia S. Al-Lamki, Jun Wang, Jun Yang, Natalie Burrows, Patrick H. Maxwell, Timothy Eisen, Anne Y. Warren, Sakari Vanharanta, Simon Pacey, Peter Vandenabeele, Jordan S. Pober, John R. Bradley

Published Mar 16, 2016 · Vol. 7, No. 17 · pp. 24111-24124

Combination of metronomic cyclophosphamide and dietary intervention inhibits neuroblastoma growth in a CD1-nu mouse model Research Paper

Raphael Johannes Morscher, Sepideh Aminzadeh-Gohari, Cornelia Hauser-Kronberger, RenÃ© GÃ¼nther Feichtinger, Wolfgang Sperl, Barbara Kofler

Published Mar 5, 2016 · Vol. 7, No. 13 · pp. 17060-17073

High LEF1 expression predicts adverse prognosis in chronic lymphocytic leukemia and may be targeted by ethacrynic acid Research Paper

Wei Wu, Huayuan Zhu, Yuan Fu, Wenyi Shen, Kourong Miao, Min Hong, Wei Xu, Lei Fan, Ken H. Young, Peng Liu, Jianyong Li

Published Feb 29, 2016 · Vol. 7, No. 16 · pp. 21631-21643

A strategy to eradicate well-developed Krebs-2 ascites in mice Research Paper

Ekaterina A. Potter, Evgenia V. Dolgova, Anastasia S. Proskurina, Alexandra M. Minkevich, Yaroslav R. Efremov, Oleg S. Taranov, Vladimir V. Omigov, Valeriy P. Nikolin, Nelly A. Popova, Sergey I. Bayborodin, Alexander A. Ostanin, Elena R. Chernykh, Nikolay A. Kolchanov, Mikhail A. Shurdov, Sergey S. Bogachev

Published Feb 10, 2016 · Vol. 7, No. 10 · pp. 11580-11594

Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma Research Paper

Qing Ye, Zijun Y. Xu-Monette, Alexandar Tzankov, Lijuan Deng, Xiaoxiao Wang, Ganiraju C. Manyam, Carlo Visco, Santiago Montes-Moreno, Li Zhang, Karen DybkÃ¦r, April Chiu, Attilio Orazi, Youli Zu, Govind Bhagat, Kristy L. Richards, Eric D. Hsi, William W.L. Choi, J. Han van Krieken, Jooryung Huh, Maurilio Ponzoni, AndrÃ©s J.M. Ferreri, Ben M. Parsons, Michael B. MÃ¸ller, Miguel A. Piris, Jane N. Winter, L. Jeffrey Medeiros, Shimin Hu, Ken H. Young

Published Nov 12, 2015 · Vol. 7, No. 3 · pp. 2401-2416

A genome-wide association study identifies WT1 variant with better response to 5-fluorouracil, pirarubicin and cyclophosphamide neoadjuvant chemotherapy in breast cancer patients Clinical Research Papers

Lina Wu, Lu Yao, Hong Zhang, Tao Ouyang, Jinfeng Li, Tianfeng Wang, Zhaoqing Fan, Tie Fan, Benyao Lin, Cameron C. Yin, Yuntao Xie

Published Nov 9, 2015 · Vol. 7, No. 4 · pp. 5042-5052

The putative oncogene, CRNDE, is a negative prognostic factor in ovarian cancer patients Research Paper

Lukasz Michal Szafron, Anna Balcerak, Ewa Anna Grzybowska, Barbara Pienkowska-Grela, Agnieszka Podgorska, Renata Zub, Magdalena Olbryt, Jolanta Pamula-Pilat, Katarzyna M. Lisowska, Ewa Grzybowska, Tymon Rubel, Agnieszka Dansonka-Mieszkowska, Bozena Konopka, Magdalena Kulesza, Martyna Lukasik, Jolanta Kupryjanczyk

Published Nov 4, 2015 · Vol. 6, No. 41 · pp. 43897-43910

Cross-talk between chronic lymphocytic leukemia (CLL) tumor B cells and mesenchymal stromal cells (MSCs): implications for neoplastic cell survival Research Paper

Valentina Trimarco, Elisa Ave, Monica Facco, Giorgia Chiodin, Federica Frezzato, Veronica Martini, Cristina Gattazzo, Federica Lessi, Carlo Alberto Giorgi, Andrea Visentin, Monica Castelli, Filippo Severin, Renato Zambello, Francesco Piazza, Gianpietro Semenzato, Livio Trentin

Published Oct 26, 2015 · Vol. 6, No. 39 · pp. 42130-42149

JNJ-26481585 primes rhabdomyosarcoma cells for chemotherapeutics by engaging the mitochondrial pathway of apoptosis Research Paper

Ulrike Heinicke, Johanna Kupka, Simone Fulda

Published Oct 12, 2015 · Vol. 6, No. 35 · pp. 37836-37851

Rituximab-induced HMGB1 release is associated with inhibition of STAT3 activity in human diffuse large B-cell lymphoma Research Paper

Tiansuo Zhao, He Ren, Xiuchao Wang, Pengfei Liu, Fan Yan, Wenna Jiang, Yang Li, Jing Li, John G Gribben, Li Jia, Jihui Hao

Published Jul 31, 2015 · Vol. 6, No. 29 · pp. 27816-27831

Phase I/II clinical trial of dendritic-cell based immunotherapy (DCVAC/PCa) combined with chemotherapy in patients with metastatic, castration-resistant prostate cancer Clinical Research Papers

Michal Podrazil, Rudolf Horvath, Etienne Becht, Daniela Rozkova, Pavla Bilkova, Hana Hromadkova, Jana Kayserova, Katerina Vavrova, Jan Lastovicka, Petra Vrabcova, Katerina Kubackova, Zdenka Gasova, Ladislav Jarolim, Marek Babjuk, Radek Spisek, Jirina Bartunkova, Jitka Fucikova

Published May 29, 2015 · Vol. 6, No. 20 · pp. 18192-18205

Hypermethylation of DAPK1 is an independent prognostic factor predicting survival in diffuse large B-cell lymphoma Research Paper

Lasse Sommer Kristensen, Fazila Asmar, Konstantinos Dimopoulos, Mette Kathrine Nygaard, Derya Aslan, Jakob Werner Hansen, Elisabeth Ralfkiaer, Kirsten GrÃ¸nbÃ¦k

Published Nov 12, 2014 · Vol. 5, No. 20 · pp. 9798-9810

Gene expression-based risk score in diffuse large B-cell lymphoma Research Paper

Published Dec 31, 2012 · Vol. 3, No. 12 · pp. 1700-1710

Keywords: DLBCL, gene expression profile, risk score, prognosis

Selenium is a modulator of circadian clock that protects mice from the toxicity of a chemotherapeutic drug via upregulation of the core clock protein, BMAL1 Research Paper

Yan Hu, Mary L. Spengler, Karen K. Kuropatwinski, Maria Comas, Marilyn Jackson, Mikhail V. Chernov, Anatoly S. Gleiberman, Natalia Fedtsova, Youcef M. Rustum, Andrei V. Gudkov, Marina Antoch

Published Dec 31, 2011 · Vol. 2, No. 12 · pp. 1279-1290

Keywords: L-Methyl-selenocysteine, TIEG1, circadian rhythms, cyclophosphamide, anticancer treatment, liver, transcription

Pilot study of a pediatric metronomic 4-drug regimen Brief Reports

Nicolas AndrÃ©, Sylvie Abed, Daniel Orbach, Corinne Armari Alla, Laetitia Padovani, Eddy Pasquier, Jean Claude Gentet, Arnauld Verschuur

Published Dec 5, 2011 · Vol. 2, No. 12 · pp. 960-965

Keywords: cancer, children, paediatric, metronomic, angiogenesis, immunity

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

A comparison of R-EPOCH and R-CHOP as a first-line regimen in de novo DLBCL patients with high Ki-67 expression in a single institution Research Paper

Thalidomide enhanced the efficacy of CHOP chemotherapy in the treatment of diffuse large B cell lymphoma: A phase II study Research Paper

The impact of adjuvant chemotherapy in older breast cancer patients on clinical and biological aging parameters Research Paper

Cardiotoxicity as indicated by LVEF and troponin T sensitivity following two anthracycline-based regimens in lymphoma: Results from a randomized prospective clinical trial Research Paper

A four gene signature of chromosome instability (CIN4) predicts for benefit from taxanes in the NCIC-CTG MA21 clinical trial Research Paper

Tumor necrosis factor receptor 2-signaling in CD133-expressing cells in renal clear cell carcinoma Research Paper

Combination of metronomic cyclophosphamide and dietary intervention inhibits neuroblastoma growth in a CD1-nu mouse model Research Paper

High LEF1 expression predicts adverse prognosis in chronic lymphocytic leukemia and may be targeted by ethacrynic acid Research Paper

A strategy to eradicate well-developed Krebs-2 ascites in mice Research Paper

Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma Research Paper

A genome-wide association study identifies WT1 variant with better response to 5-fluorouracil, pirarubicin and cyclophosphamide neoadjuvant chemotherapy in breast cancer patients Clinical Research Papers

The putative oncogene, CRNDE, is a negative prognostic factor in ovarian cancer patients Research Paper

Cross-talk between chronic lymphocytic leukemia (CLL) tumor B cells and mesenchymal stromal cells (MSCs): implications for neoplastic cell survival Research Paper

JNJ-26481585 primes rhabdomyosarcoma cells for chemotherapeutics by engaging the mitochondrial pathway of apoptosis Research Paper

Rituximab-induced HMGB1 release is associated with inhibition of STAT3 activity in human diffuse large B-cell lymphoma Research Paper

Phase I/II clinical trial of dendritic-cell based immunotherapy (DCVAC/PCa) combined with chemotherapy in patients with metastatic, castration-resistant prostate cancer Clinical Research Papers

Hypermethylation of DAPK1 is an independent prognostic factor predicting survival in diffuse large B-cell lymphoma Research Paper

Gene expression-based risk score in diffuse large B-cell lymphoma Research Paper

Selenium is a modulator of circadian clock that protects mice from the toxicity of a chemotherapeutic drug via upregulation of the core clock protein, BMAL1 Research Paper

Pilot study of a pediatric metronomic 4-drug regimen Brief Reports

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

A comparison of R-EPOCH and R-CHOP as a first-line regimen in de novo DLBCL patients with high Ki-67 expression in a single institution Research Paper

Thalidomide enhanced the efficacy of CHOP chemotherapy in the treatment of diffuse large B cell lymphoma: A phase II study Research Paper

The impact of adjuvant chemotherapy in older breast cancer patients on clinical and biological aging parameters Research Paper

Cardiotoxicity as indicated by LVEF and troponin T sensitivity following two anthracycline-based regimens in lymphoma: Results from a randomized prospective clinical trial Research Paper

A four gene signature of chromosome instability (CIN4) predicts for benefit from taxanes in the NCIC-CTG MA21 clinical trial Research Paper

Tumor necrosis factor receptor 2-signaling in CD133-expressing cells in renal clear cell carcinoma Research Paper

Combination of metronomic cyclophosphamide and dietary intervention inhibits neuroblastoma growth in a CD1-nu mouse model Research Paper

High LEF1 expression predicts adverse prognosis in chronic lymphocytic leukemia and may be targeted by ethacrynic acid Research Paper

A strategy to eradicate well-developed Krebs-2 ascites in mice Research Paper

Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma Research Paper

A genome-wide association study identifies WT1 variant with better response to 5-fluorouracil, pirarubicin and cyclophosphamide neoadjuvant chemotherapy in breast cancer patients Clinical Research Papers

The putative oncogene, CRNDE, is a negative prognostic factor in ovarian cancer patients Research Paper

Cross-talk between chronic lymphocytic leukemia (CLL) tumor B cells and mesenchymal stromal cells (MSCs): implications for neoplastic cell survival Research Paper

JNJ-26481585 primes rhabdomyosarcoma cells for chemotherapeutics by engaging the mitochondrial pathway of apoptosis Research Paper

Rituximab-induced HMGB1 release is associated with inhibition of STAT3 activity in human diffuse large B-cell lymphoma Research Paper

Phase I/II clinical trial of dendritic-cell based immunotherapy (DCVAC/PCa) combined with chemotherapy in patients with metastatic, castration-resistant prostate cancer Clinical Research Papers

Hypermethylation of DAPK1 is an independent prognostic factor predicting survival in diffuse large B-cell lymphoma Research Paper

Gene expression-based risk score in diffuse large B-cell lymphoma Research Paper

Selenium is a modulator of circadian clock that protects mice from the toxicity of a chemotherapeutic drug via upregulation of the core clock protein, BMAL1 Research Paper

Pilot study of a pediatric metronomic 4-drug regimen Brief Reports